Health Unlocked: The Power of Salutogenesis

The conversation focused on recent developments surrounding a newly granted device patent, often referred to as the "IBAL patent." A key theme that emerged was how this patent, covering ionic cofactor matrices and essential ion delivery for local applications, is shaping the strategy of a nonprofit organization dedicated to advancing this technology across various medical and commercial fields. The discussion explored the innovative spin-out model being used to create specialized development companies for different indications such as wound healing, psoriasis, eczema, and skin cancer, each benefiting from shared intellectual property while maintaining independence.
Several points were raised, including the reasoning behind a nonprofit holding patents, the benefits and challenges of the collaborative licensing approach, and the significant impact of recent reimbursement changes in wound care markets. Listeners will also hear about opportunities for researchers, practitioners, patients, and capital partners to participate in the mission, as well as new fundraising mechanisms designed to support the ongoing expansion and accessibility of the technology.

Timestamps:
00:00 Protecting and promoting the technology
04:56 Patent Strategy for Medical Applications
08:08 Collaborative model for IP sharing
13:08 Finding the right people for niche markets
16:31 Collaborating on IP development
18:27 Early manufacturing possibilities
21:10 Ion gel benefits and cost savings
25:23 Pricing Strategy and Profitability
29:38 Support for practitioners and researchers
33:00 Promoting the podcast and fundraiser
37:19 Nonprofit collaboration for fee savings
39:15 Discussing funding challenges

“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”
Show Website - https://powerofsalutogenesis.com/

Ionic Alliance Foundation Website - https://iaf.care/

Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/

TopHealth Media Website - https://tophealth.care/

Welcome back to Health Unlocked, where we dive deep into the science and strategy of healing. In today’s episode, we continue our exploration of the power of salutogenesis with Jasen Petersen. Picking up right where we left off, the conversation clarifies critical nuances from the previous episode, especially around the skepticism faced when presenting unexpected wound healing data to the medical community.
Jasen shares firsthand experiences from clinical work in Mexico, where a novel ion gel, initially introduced as a generic antimicrobial, produced unprecedented results in chronic wound healing, surprising practitioners and raising questions about the product's efficacy and underlying mechanisms. Jasen breaks down why these outcomes appear “impossible” from a conventional medical perspective, discusses the difference between cratogenic and salutogenic interventions, and dissects the challenges of presenting unconventional data to skeptical experts.
He’ll also cover practical issues in research design, data collection, and the next steps for publication, business development, and bringing this promising therapy to a larger audience. If you’re curious about the future of wound care, cellular healing, or the scientific process itself, this is an episode you won’t want to miss.

Timestamps:
00:00 Initial skepticism in Mexico markets
03:21 Ion gel heals a severe wound
07:31 Wound healing phases and products
12:42 Discussing chronic wound healing study
14:45 Discussing wound healing trials
18:52 Discussing efficacy and visual results
22:03 Zinc and copper in scar healing
26:38 Discussing limitations of cellogenic medicine
29:32 Publishing the micro immune dynamics paper
30:49 Discussing study focus on various diseases
34:17 Dealing with patents and fundraising

“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”
Show Website - https://powerofsalutogenesis.com/

Ionic Alliance Foundation Website - https://iaf.care/

Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/

TopHealth Media Website - https://tophealth.care/

Welcome back to Health Unlocked! In this episode, we dive into groundbreaking developments in wound care with Jasen Petersen, who recently attended the Symposium of Advanced Wound Care Conference in Charlotte, North Carolina. Jasen shares his experience presenting compelling clinical data on a novel topical ionic cofactor gel for chronic wounds - data so impressive that it met skepticism from the clinical community. We discuss the challenges of clinical trial design, biases in wound care research, and the hurdles of bringing innovative therapies to market, especially as a nonprofit. Jasen also gives us a glimpse into upcoming research, regulatory roadblocks, and how unconventional paths like decentralized science and industry collaboration might unlock better care for patients with chronic wounds. Stay tuned as we explore the realities, hopes, and frustrations behind changing the status quo in healthcare innovation.

Timestamps:
00:00 Talking about the conference experience
05:54 Discussing survivor bias in data
08:23 Conducting a prospective study in Mexico
10:04 Wound healing innovation conference
15:45 Using pig ECM for wound healing
19:04 Discussion on clinical trial criteria
20:10 Limitations of retrospective studies
25:43 Deciding on data collection strategy
27:19 Facing funding study challenges
30:58 Navigating US device approval
34:56 Personal experiences with a remedy
38:12 Discussing the pricing of hydrogel
41:18 Discussing KM analysis for wound closure
45:12 Building the Ionic Alliance Foundation
47:22 Product efficacy and user feedback

“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”
Show Website - https://powerofsalutogenesis.com/

Ionic Alliance Foundation Website - https://iaf.care/

Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/

TopHealth Media Website - https://tophealth.care/

Welcome back to Health Unlocked: The Power of Salutogenesis, where we explore cutting-edge ideas shaping the future of healthcare. In this episode, Jasen Petersen discusses how Ion Biotechnology is pivoting its US market entry strategy amidst shifting crypto and DeSci (Decentralized Science) market conditions. 
Instead of pursuing the costly and complex 510k regulatory pathway immediately, he reveals a new plan centered on launching the Ion Gel as a Class 1 medical device or even as a cosmetic product, leveraging the terrain support concept. This approach not only allows faster access to the US market and clinical data generation but also provides a foundation for stronger future regulatory submissions. Along the way, he covers the importance of academic publication, community involvement via token funding, and maintaining transparency as the project evolves. 
Tune in to get a real-time look at how innovation, regulation, and community engagement intersect in biotech.

Timestamps:
00:00 Finding a cost-effective FDA strategy
06:17 FDA classification and product function
09:33 Understanding product claims and regulations
12:51 Preventing diabetic foot ulcers
17:15 Overview of the research papers
21:30 Launching token before DAO
24:50 Presenting research and generating interest
27:22 FDA reclassification and strategy
31:37 Using real-world data for strategy
35:26 Navigating FDA classification challenges
38:09 Connecting with Jason and updates
39:50 Wrapping up the episode

“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”
Show Website - https://powerofsalutogenesis.com/

Ionic Alliance Foundation Website - https://iaf.care/

Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/

TopHealth Media Website - https://tophealth.care/

Welcome back to Health Unlocked! In this episode, Jasen Petersen dives into a topic that’s often underestimated in both startups and massive institutions: why good intentions just aren’t enough to drive lasting, positive change, especially in healthcare. You’ll hear how structural forces, capital pressures, and the limits of traditional governance repeatedly overpower even the most mission-driven organizations.
Using real-world examples, from the century-long journey of insulin to the rise of tech behemoths like Google, Jasen Petersen explains how systems, not simply personalities or promises, determine outcomes. He breaks down what goes wrong when intentions meet reality, and why scaling up almost always means values get tested to the breaking point.
Then, the conversation takes a fascinating turn toward solutions: exploring how decentralized science (DeSci), token-based governance, and transparent incentive structures could reshape who holds power and how decisions get made in healthcare innovation. You’ll hear exactly how Jasen Petersen is building new governance models to make sure that, this time, the “right thing” isn’t just a slogan, it’s built into the DNA of the system itself.
If you’re interested in the intersections of health, technology, economics, and mission-driven innovation, this episode is for you. Let’s get started!

Timestamps:
00:00 "Good Intentions vs. Systemic Pressures"
05:32 "Startup Governance and Capital Evolution"
08:02 "Healthcare's Free Market Misconception"
11:28 Aligned Incentives Drive Ethical Governance
14:51 "Structural Issues in Healthcare"
18:41 Decentralized IP Licensing Framework
20:58 "Impact of Poor IP Governance"
23:47 "Collaborative Data Strengthens Outcomes"
29:25 "Interconnected Innovation Strengthens IP Strategy"
33:09 "Mouthwash Innovation Through DSi"
34:11 "Decisions by Community Wisdom"
39:10 "DeSci Platform Governance Explained"
43:05 "Challenges of Broad Technology Applications"
44:07 "Structurally Durable Innovation Model"
47:50 "Ion Gel Project Updates"

“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”
Show Website - https://powerofsalutogenesis.com/

Ionic Alliance Foundation Website - https://iaf.care/

Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/

TopHealth Media Website - https://tophealth.care/